Gene · 4940
OAS3: 2'-5'-oligoadenylate synthetase 3
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. OAS3: 2'-5'-oligoadenylate synthetase 3. Genes, record 4940. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/4940
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9Y6K5 | 2'-5'-oligoadenylate synthase 3 | 1,087 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents36
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 35696 | Q9Y6K5 | Espacenet |
| EP 4640849 A2 | 2025-10-29 | 87 | Q9Y6K5 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 506 | Q9Y6K5 | Espacenet |
| JP 2025519096 A | 2025-06-24 | 87 | Q9Y6K5 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 506 | Q9Y6K5 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 141 | Q9Y6K5 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 141 | Q9Y6K5 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 103112 | Q9Y6K5 | Espacenet |
| KR 1020210130270 A | 2021-10-29 | 13 | Q9Y6K5 | Espacenet |
| JP 2021167336 A | 2021-10-21 | 13 | Q9Y6K5 | Espacenet |
1 to 10 of 36
See all 36 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,763
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | OAS3 papers | Newest fiscal year |
|---|---|---|---|
| UL1TR001863 | Yale Clinical and Translational Science Award | 6 | 2025 |
| P30AR075043 | University of Michigan Skin Biology and Diseases Resource-based Center | 5 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 4 | 2025 |
| P30CA091842 | Cancer Center Support Grant | 4 | 2025 |
| P51OD010425 | Washington National Primate Research Center | 4 | 2025 |
| P51OD011133 | The Southwest National Primate Research Center | 4 | 2025 |
| U19AI135972 | SARS-CoV adaptations through a Systems Biology Lens (SYBIL) | 4 | 2025 |
| U54CA118638 | 1/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership | 4 | 2025 |
| U54GM104938 | Oklahoma Shared Clinical and Translational Resources | 4 | 2025 |
| UL1TR002345 | Washington University Institute of Clinical and Translational Sciences | 4 | 2025 |
1 to 10 of 1,763Source NIH's project files
See all 1,763 nih grantsPapers2,054
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in Cytosolic dsRNA Sensing of Viral Infections. | Immunol Cell Biol | 2026 | 42802076 | PubTator, text mining | PubMed |
| Integrated multi-omics analysis reveals shared IFN-γ-associated monocyte signatures in primary Sjögren's syndrome and Alzheimer's disease. | Front Immunol | 2026 | 42780532 | PubTator, text mining | PubMed |
| Transcriptomic characteristics of plasma from Chinese ethnic minority patients with major depressive disorder. | Transl Psychiatry | 2026 | 42706240 | PubTator, text mining | PubMed |
| Hypomethylation of the Human OAS2 Gene in Blood Cells as a Potential Biomarker for Rheumatoid Arthritis: Findings from an Iranian Case-control Study. | Arch Iran Med | 2026 | 42604416 | PubTator, text mining | PubMed |
| Spatial decoupling of plaque and circulating immune programs defines a robust gene signature in atherosclerosis: A multi-cohort integrative analysis. | Medicine (Baltimore) | 2026 | 42601724 | PubTator, text mining | PubMed |
| Differential assembly of RNP granules via activation of distinct dsRNA sensors by adenovirus mutants. | PLoS Pathog | 2026 | 42497219 | PubTator, text mining | PubMed |
| Stage-specific disruption of erythropoiesis leads to anemia in newly diagnosed multiple myeloma patients. | Front Cell Dev Biol | 2026 | 42358738 | PubTator, text mining | PubMed |
| Proteomics-based characterization of apigenin-mediated anti-inflammatory effects in TNF-α-stimulated ARPE-19 cells. | Int Immunopharmacol | 2026 | 42322860 | PubTator, text mining | PubMed |
| Genetic variations on influenza virus infection outcomes in Moroccan patients. | Iran J Microbiol | 2026 | 42306510 | PubTator, text mining | PubMed |
| Parimifasor elicits broad-spectrum antitumor effects by suppressing the expression of oncogenic genes. | Transl Cancer Res | 2026 | 42305505 | PubTator, text mining | PubMed |
1 to 10 of 2,054
See all 2,054 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/4940
GET https://conductscience.org/api/genes/v1/4940/patents?page=2